Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

Clinical trial NCT02257528 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02257528
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Adenocarcinoma Cervical Adenosquamous Carcinoma Recurrent Cervical Carcinoma Stage IV Cervical Cancer AJCC v6 and v7 Stage IVA Cervical Cancer AJCC v6 and v7 Stage IVB Cervical Cancer AJCC v6 and v7

Start date: 2015-05-18
Primary completion: 2019-03-05
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.